Next. Vertices

Morning.

Aiyiman happily left Shanghai.

Last night.

He told his father that he wanted to farm.

I thought it was a criticism.

But quite the opposite.

He was highly praised by the prince, who praised him for being sensible and making a rare friend. This puts Aiman in a very good mood. was so excited that he almost fell in the bathroom of Tang Qing's house.

。。。

Just as Aiman was leaving.

Capital.

Aerodrome.

Next to a Boeing airliner.

A large number of doctors in white coats are boarding the plane one after another, nearly 200 people, all of whom are elite forces from major hospitals in Beijing, and this time the destination is Xin'an City.

After more than a month of discussions.

Huaxia decided.

Introduce the transcription stock.

Thereupon.

After New Year's Day.

These people were sent to learn the use of transcription stock solution for a month, during which several major hospitals in the capital would clear the floors and place new equipment.

For adjunctive treatment.

Huaxia has placed a purchase order of up to 8 billion yuan for medical equipment, which is only the first batch, and when the pilot project in Beijing is done well and achieves the expected results, it will be gradually promoted in hospitals above the top three in the country.

Until then.

The purchase volume will be more than 10 times the current scale.

In order to cooperate with and try this new diagnosis and treatment model, a temporary institution was set up --- the Big Data Medical Research Center of the Ministry of Health, and a large number of experts in the field were convened.

Whole together.

No way.

The transcription stock solution was invented.

Treatments are also well established.

You can only follow along.

Moreover, after this period of demonstration, the accurate and efficient medical advantages of big data have been unanimously affirmed by experts, because no matter how good the doctors are, they do not have hundreds of millions of treatment experience.

Pour out what he has learned all his life.

Not as good as big data.

If it goes well, Huaxia is also ready to follow the example of Myanmar Asia Pharmaceutical Group, vigorously invest in the reform of medical industrialization, and rely on the strength of the state to organize the most powerful medical scientific research force.

Defeat the disease.

R&D equipment.

Solve the problem of lack of doctors.

It can also save the cost of equipment procurement in units of 100 billion, and they can't imitate the transcription stock solution, but medical equipment is an industrial product, and Huaxia is a country with a complete industrial base.

I don't.

It also costs money.

Naturally, it is necessary to catch up.

The company said that due to the early order, it could provide all the equipment within two weeks, but considering that the installation environment was not in place, it would be after these trainees learned to return to China.

Shipped to China together.

And just the day before yesterday.

A team of experts from the Myanmar Asia Pharmaceutical Group arrived in Beijing.

Responsible for the construction guidance of the installation environment, the equipment in units of 100 million, is not just to find a place to put it, just to install the environment to build, Huaxia has paid nearly 150 million expenses.

Expensive.

It's so expensive that it hurts.

What should I do if I feel distressed?

Strive to overtake.

Master the core technology.

Hasn't Huaxia been following this path for so many years?

It is precisely because of this determination from above.

The major medical companies in China are a little anxious, before, they felt that they would not lose their jobs, but now it is not necessarily, once even the pharmaceutical research and development is taken back by the state.

So what do they do?

Production-only?

Big data medical only collects all sales.

It can be a national research institute.

They will completely lose their so-called independence, and they can't really live only on the production of drugs developed by the above, for a while, the industry panicked, and they were thinking of countermeasures, wanting to give up the idea of national research.

However.

How difficult it is.

You don't need to think about it at all.

Before.

They are companies that generate a lot of tax revenue, and they can be justified. But now, hundreds of billions of orders a year are taken by foreign pharmaceutical companies, and they can't help at all.

This is still the money for medicine.

Trillions of spending power that could be lost in the next few years.

How is this account calculated?

How do they make up?

Right now.

Due to the emergence of transcription stocks, cancer can be treated, and many companies' most profitable health care products have suddenly become a bit of a chicken rib, and even cancer is not terrible, and I am also a ghost of cancer prevention.

Tens of thousands.

My cancer was cured.

Still buy your broken pills?

It doesn't have to be effective or not.

This led to a sharp drop in sales.

Thereupon.

They're stuck here, it's an unbreakable game, and there's no reason to get the boss to take back the order, unless they can crack the preparation of the transcription stock.

It's difficult.

It's the same as the difficulty of persuasion.

。。。

Except for pharmaceutical companies.

On the one hand, big data and intelligent medical equipment can indeed solve the problem of lack of doctors, but the income of hospitals will also fall.

Machines and doctors.

The charges are definitely different.

Henceforth.

Hospitals can't even decide on the use of medicines, but the medical data centers in Beijing, what do they rely on to generate income? If it were in Western countries, those doctors would definitely take to the streets to protest.

Because it is against their interests.

affected their income.

Just last month.

A Finnish pharmaceutical company bought a set of surgical equipment from the Myanya Pharmaceutical Group, causing more than 100 surgeons to strike and take to the streets to protest against this 'soulless' treatment.

Available in Huaxia.

Who would dare to take to the streets for this?

It will definitely be smashed back by the people with rotten vegetable leaves.

。。。

Some people are bothered.

But those who understand see it very clearly.

What is the general trend?

That's irreversible by man. The boss doesn't want to solve the medical problem, but there has been no good solution, and the lives of more than a billion people are at stake.

Now.

Someone dug out a shallow passage through a dark river.

Rely on this road.

Earn a carload of gold, but also collect Huaxia's 'tolls', money by person, if you continue to wait and see, keep handing the tickets in your hand to others, isn't this stupid?

This.

Determination from above.

Rock solid.

。。。

Noon.

The plane arrived in Xin'an City.

Myanmar Asia Pharmaceutical Group gave a warm welcome, this is the first batch to come to Myanmar to study, or a big country like China, it is natural to publicize it well and strengthen the confidence of many hesitant countries.

Red carpet.

Fresh flowers.

Media.

One no less.

"Academician Ishizawa, welcome to Xin'an City again. "The vice president of the Myanmar Asia Pharmaceutical Group greeted him personally, basically the leaders who came last time, Shi Ze is an expert, but this time it was Shi Ze who led the team.

Of course.

The Ministry of Health also came.

But it's just to sign the contract, and I'm going back in two days.

"Thank you, and please don't hesitate to give me advice. Shi Ze had a good impression of this vice president who could speak Chinese, and then introduced the person next to him, "This is our Chinese academician Duan Zhihuai, who specializes in medical equipment. ”

"Hello, I will take you to the industrial park first, starting tomorrow, the class will officially start, after a week of theoretical study, I will arrange to go to major hospitals to follow the study, the third week to get started, the fourth week to test. ”

"I'm tired. ”

"You're welcome. ”